Texas Instruments 10-Q 2024-09-30
Filed 2024-10-23. 6 sections, 100K characters. Original on sec.gov · Markdown · JSON
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2024
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ___________ to ___________
Commission File Number 001-03761
TEXAS INSTRUMENTS INCORPORATED
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 75-0289970 | |||||||||||||
| (State of Incorporation) | (I.R.S. Employer Identification No.) | |||||||||||||
| 12500 TI Boulevard, Dallas, Texas | 75243 | |||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||
| Registrant’s telephone number, including area code 214-479-3773 |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Common Stock, par value $1.00 | TXN | The Nasdaq Global Select Market |
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☒ | Accelerated filer | ☐ | |||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||||||||||
| Emerging growth company | ☐ | |||||||||||||
| If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act | ☐ |
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
912,216,614
Number of shares of Registrant’s common stock outstanding as of
October 15, 2024
TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
PART I - FINANCIAL INFORMATION
Item 1. Financial statements
| For Three Months Ended | For Nine Months Ended | |||||||||||||||||||||||||
| Consolidated Statements of Income | September 30, | September 30, | ||||||||||||||||||||||||
| (In millions, except per-share amounts) | 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||||
| Revenue | $ | 4,151 | $ | 4,532 | $ | 11,634 | $ | 13,442 | ||||||||||||||||||
| Cost of revenue (COR) | 1,677 | 1,717 | 4,854 | 4,854 | ||||||||||||||||||||||
| Gross profit | 2,474 | 2,815 | 6,780 | 8,588 | ||||||||||||||||||||||
| Research and development (R&D) | 492 | 471 | 1,468 | 1,403 | ||||||||||||||||||||||
| Selling, general and administrative (SG&A) | 428 | 452 | 1,348 | 1,387 | ||||||||||||||||||||||
| Restructuring charges/other | — | — | (124) | — | ||||||||||||||||||||||
| Operating profit | 1,554 | 1,892 | 4,088 | 5,798 | ||||||||||||||||||||||
| Other income (expense), net (OI&E) | 131 | 128 | 384 | 327 | ||||||||||||||||||||||
| Interest and debt expense | 131 | 98 | 378 | 255 | ||||||||||||||||||||||
| Income before income taxes | 1,554 | 1,922 | 4,094 | 5,870 | ||||||||||||||||||||||
| Provision for income taxes | 192 | 213 | 500 | 731 | ||||||||||||||||||||||
| Net income | $ | 1,362 | $ | 1,709 | $ | 3,594 | $ | 5,139 | ||||||||||||||||||
| Earnings per common share (EPS): | ||||||||||||||||||||||||||
| Basic | $ | 1.48 | $ | 1.87 | $ | 3.92 | $ | 5.63 | ||||||||||||||||||
| Diluted | $ | 1.47 | $ | 1.85 | $ | 3.89 | $ | 5.58 | ||||||||||||||||||
| Average shares outstanding: | ||||||||||||||||||||||||||
| Basic | 913 | 908 | 912 | 908 | ||||||||||||||||||||||
| Diluted | 920 | 916 | 919 | 916 | ||||||||||||||||||||||
| A portion of net income is allocated to unvested restricted stock units (RSUs) on which we pay dividend equivalents. Diluted EPS is calculated using the following: | ||||||||||||||||||||||||||
| Net income | $ | 1,362 | $ | 1,709 | $ | 3,594 | $ | 5,139 | ||||||||||||||||||
| Income allocated to RSUs | (7) | (10) | (18) | (26) | ||||||||||||||||||||||
| Income allocated to common stock for diluted EPS | $ | 1,355 | $ | 1,699 | $ | 3,576 | $ | 5,113 | ||||||||||||||||||
| See accompanying notes. |
| For Three Months Ended | For Nine Months Ended | |||||||||||||||||||||||||
| Consolidated Statements of Comprehensive Income | September 30, | September 30, | ||||||||||||||||||||||||
| (In millions) | 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||||
| Net income | $ | 1,362 | $ | 1,709 | $ | 3,594 | $ | 5,139 | ||||||||||||||||||
| Other comprehensive income (loss) | ||||||||||||||||||||||||||
| Net actuarial losses of defined benefit plans: | ||||||||||||||||||||||||||
| Adjustments, net of tax effect of $5 and ($3); $2 and ($4) | (11) | 6 | (5) | 6 | ||||||||||||||||||||||
| Recognized within net income, net of tax effect of ($1) and ($1); ($3) and ($3) | 2 | 3 | 7 | 9 | ||||||||||||||||||||||
| Prior service cost (credit) of defined benefit plans: | ||||||||||||||||||||||||||
| Recognized within net income, net of tax effect of $0 and $0; $0 and $0 | 1 | 1 | 1 | 1 | ||||||||||||||||||||||
| Derivative instruments: | ||||||||||||||||||||||||||
| Change in fair value, net of tax effect of $0 and $0; $0 and $0 | — | — | 1 | 1 | ||||||||||||||||||||||
| Available-for-sale investments: | ||||||||||||||||||||||||||
| Unrealized gains (losses), net of tax effect of ($4) and $0; ($2) and $0 | 13 | 1 | 6 | 2 | ||||||||||||||||||||||
| Other comprehensive income (loss), net of taxes | 5 | 11 | 10 | 19 | ||||||||||||||||||||||
| Total comprehensive income | $ | 1,367 | $ | 1,720 | $ | 3,604 | $ | 5,158 | ||||||||||||||||||
| See accompanying notes. |
| September 30, | December 31, | |||||||||||||
| Consolidated Balance Sheets | 2024 | 2023 | ||||||||||||
| (In millions, except par value) | ||||||||||||||
| Assets | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ | 2,589 | $ | 2,964 | ||||||||||
| Short-term investments | 6,163 | 5,611 | ||||||||||||
| Accounts receivable, net of allowances of ($23) and ($16) | 1,862 | 1,787 | ||||||||||||
| Raw materials | 393 |
Showing the first 8K of 67K characters. Open the full section
Item 2. Management’s discussion and analysis of financial condition and results of operations
Overview
We design and manufacture semiconductors that we sell to electronics designers and manufacturers all over the world. Technology is the foundation of our company, but ultimately, our objective and the best metric for owners to measure our progress is through the growth of free cash flow per share over the long term.
Our strategy to maximize long-term free cash flow per share growth has three elements:
1.A great business model that is focused on analog and embedded processing products and built around four sustainable competitive advantages. The four sustainable competitive advantages are powerful in combination and provide tangible benefits:
i.A strong foundation of manufacturing and technology that provides lower costs and greater control of our supply chain.
ii.A broad portfolio of analog and embedded processing products that offers more opportunity per customer and more value for our investments.
iii.The reach of our market channels that gives access to more customers and more of their design projects, leading to the opportunity to sell more of our products into each design and gives us better insight and knowledge of customer needs.
iv.Diversity and longevity of our products, markets and customer positions that provide less single point dependency and longer returns on our investments.
Together, these competitive advantages help position TI in a unique class of companies capable of generating and returning significant amounts of cash for our owners. We make our investments with an eye towards long-term strengthening and leveraging of these advantages.
2.Discipline in allocating capital to the best opportunities. This spans how we select R&D projects, develop new capabilities like TI.com, invest in new manufacturing capacity or how we think about acquisitions and returning cash to our owners.
3.Efficiency, which means constantly striving for more output for every dollar spent.
We believe that our business model with the combined effect of our four competitive advantages sets TI apart from our peers and will for a long time to come. We will invest to strengthen our competitive advantages, be disciplined in capital allocation and stay diligent in our pursuit of efficiencies. Finally, we will remain focused on the belief that long-term growth of free cash flow per share is the ultimate measure to generate value.
Management’s discussion and analysis of financial condition and results of operations (MD&A) should be read in conjunction with the financial statements and the related notes that appear elsewhere in this document. In the following discussion of our results of operations:
-
Our segments represent groups of similar products that are combined on the basis of similar design and development requirements, product characteristics, manufacturing processes and distribution channels, and how management allocates resources and measures results. See Note 1 to the financial statements for more information regarding our segments.
-
When we discuss our results:
◦Unless otherwise noted, changes in our revenue are attributable to changes in customer demand, which are evidenced by fluctuations in shipment volumes.
◦New products do not tend to have a significant impact on our revenue in any given period because we sell such a large number of products.
◦From time to time, our revenue and gross profit are affected by changes in demand for higher-priced or lower-priced products, which we refer to as changes in the “mix” of products shipped.
◦Because we own much of our manufacturing capacity, a significant portion of our operating cost is fixed. When factory loadings decrease, our fixed costs are spread over reduced output and, absent other circumstances, our profit margins decrease. Conversely, as factory loadings increase, our fixed costs are spread over increased output and, absent other circumstances, our profit margins increase.
-
For an explanation of free cash flow, see the Non-GAAP financial information section.
-
All dollar amounts in the tables are stated in millions of U.S. dollars.
Performance summary
Our third quarter revenue was $4.15 billion, net income was $1.36 billion and earnings per share (EPS) were $1.47.
Revenue decreased 8% from the same quarter a year ago and increased 9% sequentially. Industrial continued to decline sequentially, while all other end markets grew.
Our cash flow from operations of $6.2 billion for the trailing 12 months again underscored the strength of our business model, the quality of our product portfolio and the benefit of 300mm production. Free cash flow for the same period was $1.5 billion.
Over the past 12 months we invested $3.7 billion in R&D and SG&A, invested $4.8 billion in capital expenditures and returned $5.2 billion to shareholders.
Results of operations – third quarter 2024 compared with third quarter 2023
Revenue of $4.15 billion decreased $381 million, or 8%, due to lower revenue from Embedded Processing and, to a lesser extent, Analog.
Gross profit of $2.47 billion was down $341 million, or 12%, primarily due to lower revenue and, to a lesser extent, higher manufacturing costs associated with our planned capacity expansions. As a percentage of revenue, gross profit decreased to 59.6% from 62.1%.
Operating expenses (R&D and SG&A) were $920 million compared with $923 million.
Operating profit was $1.55 billion, or 37.4% of revenue, compared with $1.89 billion, or 41.7% of revenue.
OI&E was $131 million of income compared with $128 million of income.
Interest and debt expense of $131 million increased $33 million due to the issuance of additional long-term debt. See Note 6 to the financial statements.
Our provision for income taxes was $192 million compared with $213 million. This decrease was primarily due to lower income before income taxes and higher discrete tax benefits.
Net income was $1.36 billion compared with $1.71 billion. EPS was $1.47 compared with $1.85.
Third quarter 2024 segment results
Our segment results compared with the year-ago quarter are as follows:
Analog (includes Power and Signal Chain product lines)
| Q3 2024 | Q3 2023 | Change | |||||||||||||||
| Revenue | $ | 3,223 | $ | 3,353 | (4) | % | |||||||||||
| Operating profit | 1,316 | 1,504 | (13) | % | |||||||||||||
| Operating profit % of revenue | 40.8 | % | 44.9 | % |
Analog revenue decreased in Signal Chain due to the mix of products shipped. Power was about even. Operating profit decreased primarily due to lower revenue and higher manufacturing costs.
Embedded Processing (includes microcontrollers and processors)
| Q3 2024 | Q3 2023 | Change | |||||||||||||||
| Revenue | $ | 653 | $ | 890 | (27) | % | |||||||||||
| Operating profit | 109 | 258 | (58) | % | |||||||||||||
| Operating profit % of revenue | 16.7 | % | 29.0 | % |
Embedded Processing revenue decreased. Operating profit decreased due to lower revenue and associated gross profit.
Other (includes DLP*®* products, calculators and custom ASIC products)
| Q3 2024 | Q3 2023 | Change | |||||||||||||||
| Revenue | $ | 275 | $ | 289 | (5) | % | |||||||||||
| Operating profit * | 129 | 130 | (1) | % | |||||||||||||
| Operating profit % of revenue | 46.9 | % | 45.0 | % | |||||||||||||
| * Includes restructuring charges/other |
Other revenue decreased $14 million, and operating profit decreased $1 million.
Results of operations – first nine months of 2024 compared with first nine months of 2023
Revenue of $11.63 billion decreased $1.81 billion, or 13%, due to lower revenue from Analog and, to a lesser extent, Embedded Processing.
Gross profit of $6.78 billion was down $1.81 billion, or 21%, primarily due to lower revenue and, to a lesser extent, higher manufacturing costs associated with our planned capacity expansions. As a percentage of revenue, gross profit decreased to 58.3% from 63.9%.
Operating expenses were $2.82 billion compared with $2.79 billion.
Restructuring charges/other was a credit of $124 million primarily due to a gain on the sale of a property during 2024.
Operating profit was $4.09 billion, or 35.1% of revenue, compared with $5.80 billion, or 43.1% of revenue.
OI&E was $384 million of income compared with $327 million of income, primarily due to higher interest income.
Interest and debt expense of $378 million increased $123 million due to the issuance of additional long-term debt.
Our provision for income taxes was $500 million compared with $731 million. This decrease was due to lower income before income taxes.
Net income was $3.59 billion compared with $5.14 billion. EPS was $3.89 compared with $5.58.
Year-to-date segment results
Our segment results compared with the year-ago period are as follows:
Analog
| YTD 2024 | YTD 2023 | Change | |||||||||||||||
| Revenue | $ | 8,987 | $ | 9,920 | (9) | % | |||||||||||
| Operating profit | 3,371 | 4,541 | (26) | % | |||||||||||||
| Operating profit % of revenue | 37.5 | % | 45.8 | % |
Analog revenue decreased due to the mix of products shipped in both product lines, led by Signal Chain. Operating profit decreased primarily due to lower revenue and higher manufacturing costs.
Embedded Processing
| YTD 2024 | YTD 2023 | Change | |||||||||||||||
| Revenue | $ | 1,920 | $ | 2,616 | (27) | % | |||||||||||
| Operating profit | 294 | 813 | (64) | % | |||||||||||||
| Operating profit % of revenue | 15.3 | % | 31.1 | % |
Embedded Processing revenue decreased. Operating profit decreased primarily due to lower revenue and associated gross profit.
Other
| YTD 2024 | YTD 2023 | Change | |||||||||||||||
| Revenue | $ | 727 | $ | 906 | (20) | % | |||||||||||
| Operating profit * | 423 | 444 | (5) | % | |||||||||||||
| Operating profit % of revenue | 58.2 | % | 49.0 | % | |||||||||||||
| * Includes restructuring charges/other |
Other revenue decreased $179 million, and operating profit decreased $21 million.
Financial condition
At the end of the third quarter of 2024, total cash (cash and cash equivalents plus short-term investments) was $8.75 billion, an increase of $177 million from the end of 2023.
Accounts receivable were $1.86 billion, an increase of $75 million compared with the end of 2023. Days sales outstanding for the third quarter of 2024 were 40 compared with 39 at the end of 2023.
Inventory was $4.30 billion, an increase of $297 million from the end of 2023. Days of inventory for the third quarter of 2024 were 231 compared with 219 at the end of 2023.
Liquidity and capital resources
Our primary source of liquidity is cash flow from operations. Additional sources of liquidity are cash and cash equivalents, short-term investments and access to debt markets. We also have a variable-rate, revolving credit facility. As of September 30, 2024, our credit facility was undrawn, and we had no commercial paper outstanding. Cash flows from operating activities for the first nine months of 2024 were $4.32 billion, a decrease of $176 million from the year-ago period primarily due to lower net income, partially offset by lower cash used for working capital. Cash flows from operating activities for the first nine months of 2024 include a cash benefit of $532 million from the U.S. CHIPS and Science Act (CHIPS Act) investment tax credit used to reduce income taxes payable.
Investing activities for the first nine months of 2024 used $3.82 billion compared with $4.05 billion in the year-ago period. Capital expenditures were $3.63 billion compared with $3.92 billion in the year-ago period and were primarily for semiconductor manufacturing equipment and facilities in both periods. Short-term investments used cash of $346 million compared with $164 million in the year-ago period.
As we continue to invest to strengthen our competitive advantage in manufacturing and technology as part of our long-term capacity planning, our capital expenditures are expected to remain at elevated levels. We expect to receive an estimated $6 billion to $8 billion through 2034 from the U.S. Department of Treasury’s investment tax credit for qualified U.S. manufacturing investments. We have received $532 million of the associated cash benefit for qualifying capital expenditures in the first nine months of 2024. Additionally, in August 2024, we signed a non-binding preliminary memorandum of terms with the U.S. Department of Commerce for up to $1.6 billion in direct funding under the CHIPS Act.
In September 2024, we announced we would increase our dividend by 5%, marking 21 consecutive years of dividend increases.
Financing activities for the first nine months of 2024 provided $879 million compared with $929 million in the year-ago period. In 2024, we received net proceeds of $2.98 billion from the issuance of fixed-rate, long-term debt and retired maturing debt of $300 million. In the year-ago period, we received net proceeds of $3.00 billion from the issuance of fixed-rate, long-term debt and retired maturing debt of $500 million. Dividends paid were $3.56 billion compared with $3.38 billion in the year-ago period, reflecting an increased dividend rate. We used $392 million to repurchase 2.0 million shares of our common stock compared with $228 million in the year-ago period to repurchase 1.3 million shares. Employee exercises of stock options provided cash proceeds of $430 million compared with $218 million in the year-ago period.
We had $2.59 billion of cash and cash equivalents and $6.16 billion of short-term investments as of September 30, 2024. We believe we have the necessary financial resources and operating plans to fund our working capital needs, capital expenditures, dividend and debt-related payments, and other business requirements for at least the next 12 months.
Non-GAAP financial information
This MD&A includes references to free cash flow and ratios based on that measure. These are financial measures that were not prepared in accordance with generally accepted accounting principles in the United States (GAAP). Free cash flow was calculated by subtracting capital expenditures from the most directly comparable GAAP measure, cash flows from operating activities (also referred to as cash flow from operations).
We believe that free cash flow and the associated ratios provide insight into our liquidity, our cash-generating capability and the amount of cash potentially available to return to shareholders, as well as insight into our financial performance. These non-GAAP measures are supplemental to the comparable GAAP measures.
Reconciliation to the most directly comparable GAAP measures is provided in the table below.
| For 12 Months Ended | |||||||||||||||||
| September 30, | |||||||||||||||||
| 2024 | 2023 | Change | |||||||||||||||
| Cash flow from operations (GAAP) * | $ | 6,244 | $ | 6,538 | (4) | % | |||||||||||
| Capital expenditures | (4,776) | (4,890) | |||||||||||||||
| Free cash flow (non-GAAP) | $ | 1,468 | $ | 1,648 | (11) | % | |||||||||||
| Revenue | $ | 15,711 | $ | 18,112 | |||||||||||||
| Cash flow from operations as a percentage of revenue (GAAP) | 39.7 | % | 36.1 | % | |||||||||||||
| Free cash flow as a percentage of revenue (non-GAAP) | 9.3 | % | 9.1 | % | |||||||||||||
- Includes a cash benefit of $532 million from the U.S. CHIPS and Science Act ITC used to reduce income taxes payable for the twelve months ended September 30, 2024
Item 4. Controls and procedures
An evaluation as of the end of the period covered by this report was carried out under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934). Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that those disclosure controls and procedures were effective. In addition, there has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II – OTHER INFORMATION
ITEM 1. Legal proceedings
Information with respect to legal proceedings can be found in Note 8 to the financial statements.
Pursuant to SEC regulation, we have elected to use a disclosure threshold of $1 million in monetary sanctions for environmental proceedings involving a governmental authority.
Item 1A. Risk factors
Information concerning our risk factors is contained in Item 1A of our Form 10-K for the year ended December 31, 2023, and is incorporated by reference herein.
ITEM 2. Unregistered sales of equity securities and use of proceeds
The following table contains information regarding our purchases of our common stock during the quarter.
ISSUER PURCHASES OF EQUITY SECURITIES
| Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (a) | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (a) | ||||||||||||||||||||||||||||||||||
| July 1, 2024 through July 31, 2024 | 91,971 | $ | 198.84 | 76,874 | $ | 21.11 | billion | |||||||||||||||||||||||||||||||
| August 1, 2024 through August 31, 2024 | 402,257 | 204.61 | 402,257 | 21.02 | billion | |||||||||||||||||||||||||||||||||
| September 1, 2024 through September 30, 2024 | 1,109,834 | 202.02 | 1,109,834 | 20.80 | billion | |||||||||||||||||||||||||||||||||
| Total | 1,604,062 | (b) | $ | 202.49 | (b) | 1,588,965 | $ | 20.80 | billion (c) |
(a)All open-market purchases during the quarter were made under the authorizations from our board of directors to purchase up to $12.0 billion and $15.0 billion of additional shares of TI common stock announced September 20, 2018, and September 15, 2022, respectively.
(b)In addition to open-market purchases, 15,097 shares of common stock were surrendered by employees to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
(c)As of September 30, 2024, this amount consisted of the remaining portion of the $12.0 billion authorized in September 2018 and the $15.0 billion authorized in September 2022. No expiration date has been specified for these authorizations.
Item 6. Exhibits
Notice regarding forward-looking statements
This report includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as TI or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements herein that describe TI’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
We urge you to carefully consider the following important factors that could cause actual results to differ materially from the expectations of TI or our management:
-
Economic, social and political conditions, and natural events in the countries in which we, our customers or our suppliers operate, including global trade policies;
-
Market demand for semiconductors, particularly in the industrial and automotive markets, and customer demand that differs from forecasts;
-
Our ability to compete in products and prices in an intensely competitive industry;
-
Evolving cybersecurity and other threats relating to our information technology systems or those of our customers, suppliers and other third parties;
-
Our ability to successfully implement and realize opportunities from strategic, business and organizational changes, or our ability to realize our expectations regarding the amount and timing of associated restructuring charges and cost savings;
-
Our ability to develop, manufacture and market innovative products in a rapidly changing technological environment, our timely implementation of new manufacturing technologies and installation of manufacturing equipment, and our ability to realize expected returns on significant investments in manufacturing capacity;
-
Availability and cost of key materials, utilities, manufacturing equipment, third-party manufacturing services and manufacturing technology;
-
Our ability to recruit and retain skilled personnel, and effectively manage key employee succession;
-
Product liability, warranty or other claims relating to our products, software, manufacturing, delivery, services, design or communications, or recalls by our customers for a product containing one of our parts;
-
Compliance with or changes in the complex laws, rules and regulations to which we are or may become subject, or actions of enforcement authorities, that restrict our ability to operate our business or subject us to fines, penalties or other legal liability;
-
Changes in tax law and accounting standards that impact the tax rate applicable to us, the jurisdictions in which profits are determined to be earned and taxed, adverse resolution of tax audits, increases in tariff rates, and the ability to realize deferred tax assets;
-
Financial difficulties of our distributors or semiconductor distributors’ promotion of competing product lines to our detriment; or disputes with current or former distributors;
-
Losses or curtailments of purchases from key customers or the timing and amount of customer inventory adjustments;
-
Our ability to maintain or improve profit margins, including our ability to utilize our manufacturing facilities at sufficient levels to cover our fixed operating costs, in an intensely competitive and cyclical industry and changing regulatory environment;
-
Our ability to maintain and enforce a strong intellectual property portfolio and maintain freedom of operation in all jurisdictions where we conduct business; or our exposure to infringement claims;
-
Instability in the global credit and financial markets; and
-
Impairments of our non-financial assets.
For a more detailed discussion of these factors, see the Risk factors discussion in Item 1A of our most recent Form 10-K. The forward-looking statements included in this report are made only as of the date of this report, and we undertake no obligation to update the forward-looking statements to reflect subsequent events or circumstances. If we do update any forward-looking statement, you should not infer that we will make additional updates with respect to that statement or any other forward-looking statement.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| TEXAS INSTRUMENTS INCORPORATED | |||||||||||
| By: | /s/ | Rafael R. Lizardi | |||||||||
| Rafael R. Lizardi, Senior Vice President and Chief Financial Officer | |||||||||||
Date: October 23, 2024